A lcase controlled study of 196k unvaccinated patients reveals: “post COVID-19 infection was not associated with either myocarditis (aHR 1.08; 95% CI 0.45 to 2.56) or pericarditis (aHR 0.53; 95% CI 0.25 to 1.13)”.
Those continuing to propagate the narrative mRNA vaccination was protective against COVID-19 induced myocarditis when there was nearly 0% risk to begin with, are simply bullshitting...
Way to go uninformed doctors, CDC, WHO personnel and the circle jerk of course....
Also, Taiwan study shows increased incidence immediately following Pfizer's 2nd booster, only problem with the study is the short time frame after the injection...
The incidence of cardiac adverse effects was reported to be as high as 1.5 per 10 000 persons after the second dose BNT162b2 COVID-19 vaccine in the young male population based on the reporting system
From the questionnaire, the incidence of cardiac-related symptoms after the second dose BNT162b2 vaccine was 17.1%, which was significantly higher than that of the first dose (5.7%, Table 1). The individual items of cardiac-related symptoms as chest pain, palpitations, and dizziness or syncope were significantly higher after the second dose of BNT162b2 vaccine (p <0.001).
The symptoms abated after a few weeks... but there was no longer term results... but there is no trivial case of myocarditis. And it was all unnecessary.
Those continuing to propagate the narrative mRNA vaccination was protective against COVID-19 induced myocarditis when there was nearly 0% risk to begin with, are simply bullshitting...
Way to go uninformed doctors, CDC, WHO personnel and the circle jerk of course....
The Incidence of Myocarditis and Pericarditis in Post COVID-19 Unvaccinated Patients—A Large Population-Based Study
Myocarditis and pericarditis are potential post-acute cardiac sequelae of COVID-19 infection, arising from adaptive immune responses. We aimed to study the incidence of post-acute COVID-19 myocarditis and pericarditis. Retrospective cohort study of 196,992 ...
www.ncbi.nlm.nih.gov
Also, Taiwan study shows increased incidence immediately following Pfizer's 2nd booster, only problem with the study is the short time frame after the injection...
The incidence of cardiac adverse effects was reported to be as high as 1.5 per 10 000 persons after the second dose BNT162b2 COVID-19 vaccine in the young male population based on the reporting system
From the questionnaire, the incidence of cardiac-related symptoms after the second dose BNT162b2 vaccine was 17.1%, which was significantly higher than that of the first dose (5.7%, Table 1). The individual items of cardiac-related symptoms as chest pain, palpitations, and dizziness or syncope were significantly higher after the second dose of BNT162b2 vaccine (p <0.001).
The symptoms abated after a few weeks... but there was no longer term results... but there is no trivial case of myocarditis. And it was all unnecessary.